Ardent Health, Inc. reported second quarter 2026 financial results for the period ended June 30, 2026. Total revenue declined 1.4% year-over-year to $1.62 billion, while net income attributable to Ardent Health fell to $17 million, or $0.12 per diluted share, compared to $73 million in the prior year period. Adjusted EBITDA decreased 32.3% to $115 million due to lower surgeries and admissions, though volumes improved after an intra-quarter update. The company reported strong operating cash flow of $197 million, a 67% increase year-over-year. Ardent Health reaffirmed its full-year 2026 revenue guidance of $6.4 billion to $6.7 billion and Adjusted EBITDA guidance of $485 million to $535 million. The company operates in the healthcare industry, providing acute care hospital services through a network of facilities across the United States.
